Impact of Mitomycin-C-Induced Neutropenia after Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery in Colorectal Cancer Patients with Peritoneal Carcinomatosis

BACKGROUND: Mitomycin-C (MMC) is the most commonly used chemotherapeutic agent for hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS). However, MMC has a side effect of myelosuppression. This study aimed to evaluate the clinical manifestations and impact of MMC-induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Suk Jun, Jeon, Youngbae, Lee, Hae Won, Kang, Jeonghyun, Baik, Seung Hyuk, Park, Eun Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810451/
https://www.ncbi.nlm.nih.gov/pubmed/34665362
http://dx.doi.org/10.1245/s10434-021-10924-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810451/
https://www.ncbi.nlm.nih.gov/pubmed/34665362
http://dx.doi.org/10.1245/s10434-021-10924-z

Ejemplares similares